Biologix has participated in the 34th Annual Conference of the Saudi Heart Association (SHA) held from October 12 to 14, 2023 as a golden sponsor. This participation aimed to foster knowledge exchange and education among consultant cardiologists, emphasizing our commitment to advancing healthcare in the MENA region.
A significant highlight of Biologix's participation was the launch of a new indication, CVRR. This groundbreaking development was shared with the main target audience - cardiologists specializing in secondary prevention for established CVD patients.
Moreover, Biologix remains dedicated to driving innovation and education in the healthcare sector, transforming patient care.
